CET+and+Interp+ C5 6

download CET+and+Interp+ C5 6

of 30

Transcript of CET+and+Interp+ C5 6

  • 8/13/2019 CET+and+Interp+ C5 6

    1/30

    Clinical Exercise Testing-

    ApplicationsPre-discharge/post MI, PTCA, CABGFunctionalDisease progressionDisability/Return to WorkDiagnostic (usually Bruce TM test)

    chest paindyspneasyncope/dizziness

  • 8/13/2019 CET+and+Interp+ C5 6

    2/30

    Diagnostic Testing-Measurements

    HR (85% PMHR) & BpSigns and symptoms

    EKG (ectopic beats and ST segment changes)

    1mm @ .08 sec = significant ST segment

    depression = ischemia

  • 8/13/2019 CET+and+Interp+ C5 6

    3/30

  • 8/13/2019 CET+and+Interp+ C5 6

    4/30

    ST-T wave segment changes

    ST depression

    ST elevation

    T wave inversion

    Ischemia

  • 8/13/2019 CET+and+Interp+ C5 6

    5/30

    ST segment slope

    Upslope less suggestive

    Flat more suggestive

    Downslope most suggestive

    Magnitude of ischemia

  • 8/13/2019 CET+and+Interp+ C5 6

    6/30

    ST Segment Depression

  • 8/13/2019 CET+and+Interp+ C5 6

    7/30

    Magnitude of ischemia is

    directly proportional to:ST segment slope

    # of EKG leads involvedPersistence of ST-T wave changes duringrecoveryAmount of ST depression (1mm vs. 5)

  • 8/13/2019 CET+and+Interp+ C5 6

    8/30

    Sensitivity/Specificity

    Sensitivity -% of patients tested who haveCAD and an abnormal test (ST chgs.)

    TPR=70% ; FPR30%

    Specificity -% of patients w/o CAD who will

    have a negative testTNR=80% ; FNR=20%

  • 8/13/2019 CET+and+Interp+ C5 6

    9/30

    False Positive Rate=30% / Factorscontributing to FPR

    Female gender (Thallium GXT)

    Resting ECG changes (LVH)

    Some meds (digitalis)

  • 8/13/2019 CET+and+Interp+ C5 6

    10/30

    Magnitude of ischemia isinversely proportional to:

    Double product (rate pressure product) SBP xHRMaximal HR achievedSBPOxygen uptake achieved

  • 8/13/2019 CET+and+Interp+ C5 6

    11/30

    Test Modalities

    CycleTM

    Arm ergometer

    advantages/disadvantages

  • 8/13/2019 CET+and+Interp+ C5 6

    12/30

    Testing Protocols-Fig. 5.3

    TMBruce/Modified Bruce

    Balke-WareUSAFSAMNaughton/Modified Naughton

    CycleYMCAPWC-170

  • 8/13/2019 CET+and+Interp+ C5 6

    13/30

    Treadmill TestingBruce Treadmill Test Stages

    Stage 1 = 1.7 mph at 10% GradeStage 2 = 2.5 mph at 12% GradeStage 3 = 3.4 mph at 14% GradeStage 4 = 4.2 mph at 16% GradeStage 5 = 5.0 mph at 18% GradeStage 6 = 5.5 mph at 20% GradeStage 7 = 6.0 mph at 22% GradeStage 8 = 6.5 mph at 24% GradeStage 9 = 7.0 mph at 26% Grade

    The Bruce Protocol Formula for Estimating VO2 Max

    For Men VO2 max = 14.8 - (1.379 x T) +(0.451 x T) - (0.012 x T)For Women VO2 max = 4.38 x T - 3.9T = Total time on the treadmill measured as a fraction of aminute (i.e.: A test time of 9 minutes 30 seconds would be

    written as T=9.5).

  • 8/13/2019 CET+and+Interp+ C5 6

    14/30

    VO2 MaxNorms for

    Men -Measured

    inml/kg/min

    Age Very Poor Poor Fair Good Excellent Superior

    13-19 55.9

    20-29 52.4

    30-39 49.440-49 48.0

    50-59 45.3

    60+ 44.2

    Bruce Norms

  • 8/13/2019 CET+and+Interp+ C5 6

    15/30

    VO2 Maxvalues forWomen asmeasured

    in

    ml/kg/minAge Very Poor Poor Fair Good Excellent Superior13-19 41.920-29 41.030-39 40.0

    40-49 36.950-59 35.760+ 31.4

    Bruce Norms

  • 8/13/2019 CET+and+Interp+ C5 6

    16/30

    Functional Aerobic Impairment(FAI)

    % FAI = predicted VO2 measured VO2 x 100

    predicted VO2

    Predicted (male): 57.8 (.445 x age)

    Measured: 14.8 - (1.379 x T) + (0.451 x T) -(0.012 x T)

  • 8/13/2019 CET+and+Interp+ C5 6

    17/30

    Example-FAI

    50 y/o male

    Predicted Vo2 = 57.8 (.445 x 50) = 35.5 ml/kg/min

    Measured VO2 = 20.2 ml/kg/min (TM time)

    35.5 20.2

    FAI = ______________ x 100 = 43%35.5

    FAC = 57%

  • 8/13/2019 CET+and+Interp+ C5 6

    18/30

    Protocols cont.

    Step wise vs. rampIncrements 8-12 mins

    HR, BP & ECG monitored pre-post exercise(6-8 mins or until any changes return to baseline(Table 5.2)RPE, angina scale & claudication scales(Fig.5.4)

  • 8/13/2019 CET+and+Interp+ C5 6

    19/30

    Indications for stopping a test(Box 5.2) Absolute/Relative

    Drop in SBP (>10 mmHg) with other signs ifischemia?Mod-severe angina (3 on standard scale)Sustained ventricular tachycardiaST elevation (1.0 mm)Excessive ST depression (>2mm horizontal ordownsloping)arrhythmias

  • 8/13/2019 CET+and+Interp+ C5 6

    20/30

    Gas exchange and ventilatorymeasurements: CP-GXT

    Utility:Accuracy of VO2 measurement

    Distinguish b/w cardiac and pulmonary limitations(dyspnea)Additional assessments of cardiac function (O2pulse; VTh)Rule out malingering (RER)

  • 8/13/2019 CET+and+Interp+ C5 6

    21/30

    Critical Measurements:

    HR, Bp, EKG and signs/symptomsVO2 measured vs. estimated (obesity; lungdisease)

    VE airflow limitation? (VE/MVV)RER effortVTh cardiac function

    VE/VO2 ; VE/VCO2 ventilating efficiencySaO2 or PaO2 gas exchange limitation?O2 pulse VO2/HR (indirect indicator of SV)

  • 8/13/2019 CET+and+Interp+ C5 6

    22/30

    Thallium 201 Stress Test

    (or Technetium99

    )

  • 8/13/2019 CET+and+Interp+ C5 6

    23/30

    Thallium Scan

  • 8/13/2019 CET+and+Interp+ C5 6

    24/30

    Echocardiography (Ultrasound)

    Transesophageal echocardiogram. Doppler echocardiogram. Stress echocardiogram.

    Mitral valveprolapseLVH

  • 8/13/2019 CET+and+Interp+ C5 6

    25/30

    Pharmacological Stress Testing

    Dobutamine stress echo detection of wallmotion abnormalities (+ chronotropic agent)

    Dipyridamole (persantine) or adenosine vasodilators used to assess coronaryperfusion in conjunction with a nuclearimaging agent (increased blood flow innormal CA; steals blood flow from stenoticvessels)Accuracy = ~86%

  • 8/13/2019 CET+and+Interp+ C5 6

    26/30

    Considerations for PulmonaryPatients-Essential Measurements

    Spirometry (FVC, FEV1, MVV, TLC)VE (VE/MVV) -calculation of breathing reserve

    airflow limitation SaO2/PaO2 oxygenation gas exchangelimitation; ABG or pulse oximetry

    VO2/VCO2 (direct measurements)VT and Fb

  • 8/13/2019 CET+and+Interp+ C5 6

    27/30

    Asthma and Exercise-InducedAsthma (EIA)

    Incidence 20 million; by ~5% per year80% of asthmatics have EIA (EIB)

    Only 5-15% of non asthmatics have EIAHigh incidence in winter sport athletes (40-50%)

    Mechanism : loss of H2O and airway drying histamine from mast cells bronchoconstriction and inflammation

  • 8/13/2019 CET+and+Interp+ C5 6

    28/30

    Asmogenic Agents/Symptoms

    Allergensanimal dander, dust mites, pollen

    Irritantssmoke, air pollution, cold air, sulfites (wine),chlorine?

    Exercise (especially in cold air)

    Symptoms

    cough, wheeze, dyspnea, chest tightness

  • 8/13/2019 CET+and+Interp+ C5 6

    29/30

    Testing Protocols for EIA(bronchial provocation test)

    85% PMHR ( VE)

    6-8 mins durationFEV1 measured before and at 5 min intervalsafter exercise

    15 % drop in FEV1 = EIA

    f

  • 8/13/2019 CET+and+Interp+ C5 6

    30/30

    Testing for PVDAnkle-brachial index (ABI)

    Arterial pedal pulses dopplertibialis anteriorposterior pedal

    Normal value > .90Example:At rest: ankle = 110 ; brachial = 120 110/120 = .91Moderate-to-Severe Occlusion (post-exercise)ankle = 70; brachial = 140 70/140 = .50